|Articles|June 22, 2016

CenterWatch Joins WIRB-Copernicus Group

WIRB-Copernicus Group has acquired clinical trials information provider CenterWatch, and added its founder and owner, Kenneth A. Getz, to WCG’s board of directors.

WIRB-Copernicus Group has acquired clinical trials information provider CenterWatch, and added its founder and owner, Kenneth A. Getz, to WCG’s board of directors. According to WCG, the acquisition will facilitate an increase in sharing of knowledge and communication among key stakeholders in clinical research.

Read the full release here

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

CenterWatch Joins WIRB-Copernicus Group

Related Content

PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety

What Clinical Trials Can Learn from the Gig Economy About Payments

How the Line Between Clinical Data and Real-World Evidence Is Blurring

ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics

Quantifying the Net Financial Value of Deploying Risk-Based Quality Management

Trending on Applied Clinical Trials Online

Quantifying the Net Financial Value of Deploying Risk-Based Quality Management

ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics

AI-Driven Clinical Trial Recruitment and Design

ACT Brief: Quality Built Throughout Trial Lifecycle, Agentic RTSM Compression, and State Access Programs

PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety